This article has an unclear citation style .(August 2024) |
Roger J. Davis is a molecular biologist. He is the H. Arthur Smith Chair in Cancer Research at the University of Massachusetts Medical School. Davis is known for his research on signaling mechanisms related to the body's response to stress. His laboratory identified the human cJun NH2-terminal kinase (JNK) pathway, which mediates stress responses. His research has contributed to understanding mechanisms involved in normal physiology and various diseases, including inflammation, diabetes, cancer, and neurodegeneration. He is an elected member of the National Academy of Medicine.
Davis received his early education at Loose Primary School in Loose, Kent, UK, from 1966 to 1969, followed by Maidstone Grammar School in Maidstone, Kent, UK, from 1969 to 1976. He then attended Cambridge University (Queens' College), where he completed his undergraduate studies from 1976 to 1979, earning a BA, and continued as a graduate student from 1979 to 1982, obtaining an MPhil, MA, and PhD. He is recognized as an eminent alumnus of Queens' College, Cambridge. [1]
Davis began his career as a Research Fellow at Queens' College, Cambridge University from 1983 to 1985. He then served as a Damon Runyon Post-doctoral Fellow at the University of Massachusetts Medical School from 1984 to 1985. [2] Davis joined the Department of Biochemistry at the University of Massachusetts Medical School as an assistant professor from 1985 to 1989, later becoming an associate professor from 1989 to 1993. [3] He was an investigator at the Howard Hughes Medical Institute from 1990 to 2019. [4] Since 1993, he has been a professor in the Program in Molecular Medicine at the University of Massachusetts Medical School, where he also holds the H. Arthur Smith Endowed Chair since 2002 [5] and has served as chair of the Program in Molecular Medicine at the University of Massachusetts Chan Medical School since 2019. [3]
UMass Chan Medical School is a public medical school in Worcester, Massachusetts. It is part of the University of Massachusetts system. It is home to three schools: the T.H. Chan School of Medicine, the Morningside Graduate School of Biomedical Sciences, and the Tan Chingfen Graduate School of Nursing, as well as a biomedical research enterprise and a range of public-service initiatives throughout the state.
Jonathan Roger Beckwith is an American microbiologist and geneticist. He is the American Cancer Society Professor in the Department of Microbiology and Immunobiology at Harvard Medical School in Boston, Massachusetts.
Andrew Zachary Fire is an American biologist and professor of pathology and of genetics at the Stanford University School of Medicine. He was awarded the 2006 Nobel Prize in Physiology or Medicine, along with Craig C. Mello, for the discovery of RNA interference (RNAi). This research was conducted at the Carnegie Institution of Washington and published in 1998.
Eric D. Green is an American genomics researcher who had significant involvement in the Human Genome Project. He is the director of the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH), a position he has held since 2009.
Edward Francis DeLong, is a marine microbiologist and professor in the Department of Oceanography at the University of Hawaii, Manoa, and is considered a pioneer in the field of metagenomics. He is best known for his discovery of the bacterial use of the rhodopsin protein in converting sunlight to biochemical energy in marine microbial communities.
Roger Sidney Goody is an English biochemist who served as director at the Max Planck Institute for Molecular Physiology in Dortmund from 1993 until 2013. Since 2013 he is Emeritus Director of the institute.
Katherine A. Fitzgerald is an Irish-born American molecular biologist and virologist. She is a professor of medicine currently working in the Division of Infectious Disease at the University of Massachusetts Medical School. She is also the director of the Program in Innate Immunity.
Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.
David Chaim Rubinsztein FRS FMedSci is the Deputy Director of the Cambridge Institute of Medical Research (CIMR), Professor of Molecular Neurogenetics at the University of Cambridge and a UK Dementia Research Institute Professor.
Sir Hugh Reginald Brentnall Pelham, is a cell biologist who has contributed to our understanding of the body's response to rises in temperature through the synthesis of heat shock proteins. He served as director of the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) between 2006 and 2018.
Luke Anthony John O'Neill is an Irish biochemist. He has been a professor of biochemistry in the School of Biochemistry and Immunology at Trinity College Dublin since 2009.
Michael Green was an American molecular biologist and cell biologist at the University of Massachusetts Medical School, where he was the chair of the Department of Molecular, Cell and Cancer Biology, director of the UMass Cancer Center, and a Howard Hughes Medical Institute investigator. Green was a member of the National Academy of Sciences and the National Academy of Medicine.
Anne Jacqueline Ridley is professor of Cell Biology and Head of School for Cellular and Molecular Medicine at the University of Bristol. She was previously a professor at King's College London.
Michael Karin is an Israeli-American Distinguished Professor of Pharmacology, Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases, and American Cancer Society Research Professor at the University of California, San Diego.
Phillip D. Zamore is an American molecular biologist and biochemist who co-developed the first in vitro system for studying the mechanism of RNA interference (RNAi). He is the Gretchen Stone Cook Professor of Biomedical Sciences at University of Massachusetts Chan Medical School, Worcester, Massachusetts. Zamore is chair of the RNA Therapeutics Institute (RTI), established in 2009, and has been a Howard Hughes Medical Institute Investigator since 2008.
Patricia Kilroy Donahoe is an American pediatric surgeon and a leading researcher in the field of developmental biology and oncology. She was the president of the American Pediatric Surgical Association from 2006 to 2007. She currently serves as the director of pediatric surgical research laboratories and chief emerita of pediatric surgical services at Massachusetts General Hospital.
Joseph Heitman is an American physician-scientist focused on research in genetics, microbiology, and infectious diseases. He is the James B. Duke Professor and Chair of the Department of Molecular Genetics and Microbiology at Duke University School of Medicine.
Hudson Hoagland was an American neuroscientist, president of the American Academy of Arts and Sciences, from 1961 to 1964.
Melissa J. Moore is an American biochemist who focuses on RNA. She was the Chief Scientific Officer of Moderna from 2016-2023, where her team contributed to the development of the Moderna COVID-19 vaccine.
Susan Mary Lea is a British biologist who serves as chief of the center for structural biology at the National Cancer Institute. Her research investigates host-pathogen interactions and biomolecular pathways. She was elected a Fellow of the Royal Society in 2022.